Kimberly McMahon
Chgo, ILNPI 1922101831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 29.0% of the total.
Across 139 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$840
- Organon$263
- Hologic Sales And Service, LLC$185
- Coopersurgical, Inc.$163
- Astellas Pharma US Inc$161
- Avion Pharmaceuticals$135
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,82097%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $840 |
| Organon | 17 | $263 |
| Hologic Sales And Service, LLC | 10 | $185 |
| Coopersurgical, Inc. | 9 | $163 |
| Astellas Pharma US Inc | 6 | $161 |
| Avion Pharmaceuticals | 5 | $135 |
| Exeltis, USA Inc. | 6 | $130 |
| Mayne Pharma Commercial LLC | 8 | $129 |
| Channel Medsystems, Inc. | 3 | $122 |
| Bayer | 5 | $115 |
| Merck | 6 | $101 |
| Myovant Sciences Inc. | 3 | $85 |
| AMAG Pharmaceuticals, Inc. | 4 | $73 |
| Biogen | 3 | $63 |
| Millicent US Inc | 3 | $53 |
| Exact Sciences | 2 | $41 |
| Pfizer | 2 | $41 |
| BD | 1 | $35 |
| Novo Nordisk | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Boston Scientific | 1 | $29 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Mission Pharmacal Company | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.